Please wait a minute...
J Zhejiang Univ (Med Sci)  2022, Vol. 51 Issue (1): 108-114    DOI: 10.3724/zdxbyxb-2021-0111
    
Research progress on the relationship between chronic periodontitis and Parkinson’s disease
BIAN Mengyao,CHEN Lili,LEI Lihong()
Department of Periodontology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China
Download: HTML( 10 )   PDF(2069KB)
Export: BibTeX | EndNote (RIS)      

Abstract  

Chronic periodontitis is an infectious disease, which has a reciprocal relationship with a variety of systemic disorders. Parkinson’s disease is a prevalent neurodegenerative disease in which inflammation plays an important role for its progression. A vast number of studies suggest that there is a potential connection between chronic periodontitis and neurodegenerative diseases such as Parkinson’s disease. Individuals with Parkinson’s disease usually have poor periodontal health, and their oral flora composition differs from that of healthy people; at the same time, patients with chronic periodontitis have a higher risk of Parkinson’s disease, which can be reduced with regular periodontal treatment. In fact, the mechanism of interaction between chronic periodontitis and Parkinson’s disease is not clear. According to several studies, the clinical symptoms of Parkinson’s disease prevent patients to maintain oral hygiene effectively, increasing the risk of periodontitis. Neuroinflammation mediated by microglia may be the key to the influence of chronic periodontitis on Parkinson’s disease. Periodontal pathogens and inflammatory mediators may enter the brain and activate microglia in various ways, and ultimately leading to occurrence and development of Parkinson’s disease. This article reviews the recent research progress on the association between chronic periodontitis and Parkinson’s disease, and its potential mechanism to provide information for further research.



Key wordsChronic periodontitis      Parkinson’s disease      Neuroinflammation      Microglia      Periodontal bacteria      Review     
Received: 24 October 2021      Published: 17 May 2022
CLC:  R781.4  
  R749.1  
Corresponding Authors: LEI Lihong     E-mail: kqllh@zju.edu.cn
Cite this article:

BIAN Mengyao,CHEN Lili,LEI Lihong. Research progress on the relationship between chronic periodontitis and Parkinson’s disease. J Zhejiang Univ (Med Sci), 2022, 51(1): 108-114.

URL:

https://www.zjujournals.com/med/10.3724/zdxbyxb-2021-0111     OR     https://www.zjujournals.com/med/Y2022/V51/I1/108


慢性牙周炎与帕金森病相关性的研究进展

慢性牙周炎属于慢性感染性疾病,与多种全身疾病存在双向关系。帕金森病是一种常见的神经退行性变性疾病,炎症反应在其进展中起到一定作用。近年来,大量研究提示慢性牙周炎与帕金森病等神经退行性变性疾病之间存在潜在联系,帕金森病患者牙周状况较差,其口腔菌群组成与健康人群存在差异;与此同时,慢性牙周炎患者罹患帕金森病的风险更高,定期牙周治疗可能在一定程度上降低该风险。慢性牙周炎与帕金森病的相互作用机制尚未明确,部分研究认为帕金森病患者可能由于运动及非运动症状,无法有效维护口腔卫生,增加牙周炎患病风险;小胶质细胞介导的神经炎症则可能是慢性牙周炎影响帕金森病的关键,牙周致病菌及炎症介质或可通过多种途径进入大脑并激活小胶质细胞,最终影响帕金森病的发生发展。本文就慢性牙周炎与帕金森病相关性及可能的交互作用机制的最新研究进展作一综述,以期为进一步探讨两者相互影响的研究提供思路。


关键词: 慢性牙周炎,  帕金森病,  神经炎症,  小胶质细胞,  牙周致病菌,  综述 
[1]   王 兴. 第四次全国口腔健康流行病学调查报告[M]. 北京: 人民卫生出版社, 2018: 106-113
[2]   GENCOR J, SANZM. Clinical and public health implications of periodontal and systemic diseases: an overview[J]Periodontol 2000, 2020, 83( 1): 7-13.
doi: 10.1111/prd.12344
[3]   刘疏影, 陈 彪. 帕金森病流行现状[J]. 中国现代神经疾病杂志, 2016, 16(2): 98-101
LIU Shuying, CHEN Biao. Epidemiology of Parkinson’s disease[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2016, 16(2): 98-101. (in Chinese)
[4]   DORSEYE R, CONSTANTINESCUR, THOMPSONJ P, et al.Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030[J]Neurology, 2007, 68( 5): 384-386.
doi: 10.1212/01.wnl.0000247740.47667.03
[5]   KALIAL V, LANGA E. Parkinson’s disease[J]Lancet, 2015, 386( 9996): 896-912.
doi: 10.1016/S0140-6736(14)61393-3
[6]   DICKSOND W, BRAAKH, DUDAJ E, et al.Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria[J]Lancet Neurol, 2009, 8( 12): 1150-1157.
doi: 10.1016/s1474-4422(09)70238-8
[7]   JOHNSONM E, STECHERB, LABRIEV, et al.Triggers, facilitators, and aggravators: redefining parkinson’s disease pathogenesis[J]Trends Neuroscis, 2019, 42( 1): 4-13.
doi: 10.1016/j.tins.2018.09.007
[8]   BURBULLAL F, SONGP, MAZZULLIJ R, et al.Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease[J]Science, 2017, 357( 6357): 1255-1261.
doi: 10.1126/science.aam9080
[9]   PUSPITAL, CHUNGS Y, SHIMJ W. Oxidative stress and cellular pathologies in Parkinson’s disease[J]Mol Brain, 2017, 10( 1): 53.
doi: 10.1186/s13041-017-0340-9
[10]   YANJ, FUQ, CHENGL, et al.Inflammatory response in Parkinson’s disease (Review)[J]Mol Med Rep, 2014, 10( 5): 2223-2233.
doi: 10.3892/mmr.2014.2563
[11]   李 琳, 王 丹, 赵曼竹, 等. 慢性牙周炎与神经退行性疾病相关性的研究进展[J]. 国际口腔医学杂志, 2017, 44(5): 514-518
LI Lin, WANG Dan, ZHAO Manzhu, et al. Research progress on the correlation between chronic periodontitis and neurodegenerative diseases[J]. Internation Journal of Stomatology, 2017, 44(5): 514-518. (in Chinese)
[12]   HASHIOKAS, INOUEK, MIYAOKAT, et al.The possible causal link of periodontitis to neuropsychiatric disorders: more than psychosocial mechanisms[J]Int J Mol Sci, 2019, 20( 15): 3723.
doi: 10.3390/ijms20153723
[13]   钱雪申, 葛 颂. 慢性牙周炎与阿尔茨海默病关系的研究现状[J]. 中华口腔医学杂志, 2018, 53(4): 275-279
QIAN Xueshen, GE Song.The state of the art research findings on the relationship between chronic periodontitis and Alzheimer’s disease: a review[J]. Chinese Journal of Stomatology, 2018, 53(4): 275-279. (in Chinese)
[14]   SCHWARZJ, HEIMHILGERE, STORCHA. Increased periodontal pathology in Parkinson’s disease[J]J Neurol, 2006, 253( 5): 608-611.
doi: 10.1007/s00415-006-0068-4
[15]   EINARSDÓTTIRE R, GUNNSTEINSDÓTTIRH, HALLSDÓTTIRM H, et al.Dental health of patients with Parkinson’s disease in Iceland[J]Spec Care Dent, 2009, 29( 3): 123-127.
doi: 10.1111/j.1754-4505.2009.00075.x
[16]   HANAOKAA, KASHIHARAK. Increased frequencies of caries, periodontal disease and tooth loss in patients with Parkinson’s disease[J]J Clin Neurosci, 2009, 16( 10): 1279-1282.
doi: 10.1016/j.jocn.2008.12.027
[17]   MÜLLERT, PALLUCHR, ACKOWSKIJ J. Caries and periodontal disease in patients with Parkinson’s disease[J]Spec Care Dent, 2011, 31( 5): 178-181.
doi: 10.1111/j.1754-4505.2011.00205.x
[18]   PRADEEPA R, SINGHS P, MARTANDES S, et al.Clinical evaluation of the periodontal health condition and oral health awareness in Parkinson’s disease patients[J]Gerodontology, 2015, 32( 2): 100-106.
doi: 10.1111/ger.12055
[19]   BAKKEM, LARSENS L, LAUTRUPC, et al.Orofacial function and oral health in patients with Parkinson’s disease[J]Eur J Oral Sci, 2011, 119( 1): 27-32.
doi: 10.1111/j.1600-0722.2010.00802.x
[20]   VAN STIPHOUTM A E, MARINUSJ, VAN HILTENJ J, et al.Oral health of parkinson’s disease patients: a case-control study[J]Parkinsons Dis, 2018, 1-8.
doi: 10.1155/2018/9315285
[21]   LYRAP, MACHADOV, PROENÇAL, et al.Parkinson’s disease, periodontitis and patient-related outcomes: a cross-sectional study[J]Medicina, 2020, 56( 8): 383.
doi: 10.3390/medicina56080383
[22]   PATINIR. Oral microbiota: discovering and facing the new associations with systemic diseases[J]Pathogens, 2020, 9( 4): 313.
doi: 10.3390/pathogens9040313
[23]   PEREIRAP A B, AHOV T E, PAULINL, et al.Oral and nasal microbiota in Parkinson’s disease[J]Parkinsonism Relat Disord, 2017, 61-67.
doi: 10.1016/j.parkreldis.2017.02.026
[24]   ROZASN S, TRIBBLEG D, JETERC B. Oral factors that impact the oral microbiota in parkinson’s disease[J]Microorganisms, 2021, 9( 8): 1616.
doi: 10.3390/microorganisms9081616
[25]   FLEURYV, ZEKERIDOUA, LAZAREVICV, et al.Oral dysbiosis and inflammation in Parkinson’s disease[J]J Parkinson Dis, 2021, 11( 2): 619-631.
doi: 10.3233/JPD-202459
[26]   MIHAILAD, DONEGANJ, BARNSS, et al.The oral microbiome of early stage Parkinson’s disease and its relationship with functional measures of motor and non-motor function[J/OL]PLoS One, 2019, 14( 6): e0218252.
doi: 10.1371/journal.pone.0218252
[27]   KAURT, UPPOORA, NAIKD. Parkinson’s disease and periodontitis——the missing link? A review[J]Gerodontology, 2016, 33( 4): 434-438.
doi: 10.1111/ger.12188
[28]   SHENC C, TSAIS J, PERNGC L, et al.Risk of Parkinson disease after depression: a nationwide population-based study[J]Neurology, 2013, 81( 17): 1538-1544.
doi: 10.1212/WNL.0b013e3182a956ad
[29]   SABBAHW, GOMAAN, GIREESHA. Stress, allostatic load, and periodontal diseases[J]Periodontol 2000, 2018, 78( 1): 154-161.
doi: 10.1111/prd.12238
[30]   LIUT C, SHEUJ J, LINH C, et al.Increased risk of parkinsonism following chronic periodontitis: a retrospective cohort study[J]Mov Disord, 2013, 28( 9): 1307-1308.
doi: 10.1002/mds.25359
[31]   CHENC K, WUY T, CHANGY C. Periodontal inflammatory disease is associated with the risk of Parkinson’s disease: a population-based retrospective matched-cohort study[J/OL]PeerJ, 2017, e3647.
doi: 10.7717/peerj.3647
[32]   JEONGE, PARKJ B, PARKY G. Evaluation of the association between periodontitis and risk of Parkinson’s disease: a nationwide retrospective cohort study[J]Sci Rep, 2021, 11( 1): 16594.
doi: 10.1038/s41598-021-96147-4
[33]   WOOH G, CHANGY, LEEJ S, et al.Association of tooth loss with new-onset Parkinson’s disease: a nationwide population-based cohort study[J]Parkinsons Dis, 2020, 4760512.
doi: 10.1155/2020/4760512
[34]   CHENC K, HUANGJ Y, WUY T, et al.Dental scaling decreases the risk of Parkinson’s disease: a nationwide population-based nested case-control study[J]Int J Environ Res Public Health, 2018, 15( 8): 1587.
doi: 10.3390/ijerph15081587
[35]   LEDWONB, MISKIEWICZA, GRABOWSKAE, et al.The relationship between periodontal disease and motor impairment in the course of Parkinson’s disease[J]Postepy Hig Med Dosw, 2020, 340-347.
doi: 10.5604/01.3001.0014.3516
[36]   FROSTJ L, SCHAFERD P. Microglia: architects of the developing nervous system[J]Trends Cell Biol, 2016, 26( 8): 587-597.
doi: 10.1016/j.tcb.2016.02.006
[37]   GERHARDA, PAVESEN, HOTTONG, et al.In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson’s disease[J]NeuroBiol Dis, 2006, 21( 2): 404-412.
doi: 10.1016/j.nbd.2005.08.002
[38]   申 杰, 徐桂华. 血脑屏障与中枢神经系统疾病的相关性研究进展[J]. 中华神经医学杂志, 2020, 19(9): 961-965
SHEN Jie, XU Guihua. Recent advance in relation between blood-brain barrier and central nervous system diseases[J]. Chinese Journal of Neuromedicine, 2020, 19(9): 961-965. (in Chinese)
[39]   GRAYM T, WOULFEJ M. Striatal blood-brain barrier permeability in Parkinson’s disease[J]J Cereb Blood Flow Metab, 2015, 35( 5): 747-750.
doi: 10.1038/jcbfm.2015.32
[40]   DICKSTEINJ B, MOLDOFSKYH, HAYJ B. Brain-blood permeability: TNF-α promotes escape of protein tracer from CSF to blood[J]Am J Physiol-Regulatory Integrative Comp Physiol, 2000, 279( 1): R148-R151.
doi: 10.1152/ajpregu.2000.279.1.R148
[41]   NAVARATHNAD H M L P, MUNASINGHEJ, LIZAKM J, et al.MRI confirms loss of blood-brain barrier integrity in a mouse model of disseminated candidiasis[J]NMR Biomed, 2013, 26( 9): 1125-1134.
doi: 10.1002/nbm.2926
[42]   FRYM, FERGUSONA V. The sensory circumventricular organs: brain targets for circulating signals controlling ingestive behavior[J]Physiol Behav, 2007, 91( 4): 413-423.
doi: 10.1016/j.physbeh.2007.04.003
[43]   WARDLAWJ M, BENVENISTEH, NEDERGAARDM, et al.Perivascular spaces in the brain: anatomy, physiology and pathology[J]Nat Rev Neurol, 2020, 16( 3): 137-153.
doi: 10.1038/s41582-020-0312-z
[44]   FREIREM, NELSONK E, EDLUNDA. The oral host——microbial interactome: an ecological chronometer of health?[J]Trends Microbiol, 2021, 29( 6): 551-561.
doi: 10.1016/j.tim.2020.11.004
[45]   XUEL, ZOUX, YANGX Q, et al.Chronic periodontitis induces microbiota-gut-brain axis disorders and cognitive impairment in mice[J]Exp Neurol, 2020, 113176.
doi: 10.1016/j.expneurol.2020.113176
[46]   LANZAE, MAGAN-FERNANDEZA, BERMEJOB, et al.Complementary clinical effects of red complex bacteria on generalized periodontitis in a caucasian population[J]Oral Dis, 2016, 22( 5): 430-437.
doi: 10.1111/odi.12471
[47]   DOMINYS S, LYNCHC, ERMINIF, et al.Porphyromonas gingivalis in Alzheimer’s disease brains: evidence for disease causation and treatment with small-molecule inhibitors[J/OL]Sci Adv, 2019, 5( 1): eaau3333.
doi: 10.1126/sciadv.aau3333
[48]   ADAMSB, NUNESJ M, PAGEM J, et al.Parkinson’s disease: a systemic inflammatory disease accompanied by bacterial inflammagens[J]Front Aging Neurosci, 2019, 210.
doi: 10.3389/fnagi.2019.00210
[49]   OLSENI, KELLD B, PRETORIUSE. Is porphyromonas gingivalis involved in Parkinson’s disease?[J]Eur J Clin Microbiol Infect Dis, 2020, 39( 11): 2013-2018.
doi: 10.1007/s10096-020-03944-2
[50]   FRISTERA, SCHMIDTC, SCHNEBLEN, et al.Phosphoinositide 3-kinase γ affects LPS-induced disturbance of blood-brain barrier via lipid kinase-independent control of cAMP in microglial cells[J]Neuromol Med, 2014, 16( 4): 704-713.
doi: 10.1007/s12017-014-8320-z
[51]   HERRERAA J, CASTAÑOA, VENEROJ L, et al.The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system[J]NeuroBiol Dis, 2000, 7( 4): 429-447.
doi: 10.1006/nbdi.2000.0289
[52]   RANJANR, ABHINAYA, MISHRAM. Can oral microbial infections be a risk factor for neurodegeneration? A review of the literature[J]Neurol India, 2018, 66( 2): 344.
doi: 10.4103/0028-3886.227315
[53]   DANIELYANL, SCHÄFERR, VON AMELN-MAYERHOFERA, et al.Intranasal delivery of cells to the brain[J]Eur J Cell Biol, 2009, 88( 6): 315-324.
doi: 10.1016/j.ejcb.2009.02.001
[54]   王 鹞, 吕慧欣, 杜留熠, 等. 软脑膜在外周炎症影响神经炎症过程中的作用[J]. 国际口腔医学杂志, 2019, 46(2): 223-227
WANG Yao, LYU Huixin, DU Liuyi, et al. Roles of leptomeninges in the effect of chronic peripheral inflammation on neuroinflammation[J]. International Journal of Stomatology, 2019, 46(2): 223-227. (in Chinese)
[55]   LIUY, WUZ, ZHANGX, et al.Leptomeningeal cells transduce peripheral macrophages inflammatory signal to microglia in reponse to porphyromonas gingivalis LPS[J]Mediators Inflamm, 2013, 407562.
doi: 10.1155/2013/407562
[56]   CHAOY, WONGS C, TANE K. Evidence of inflammatory system involvement in Parkinson’s disease[J]Biomed Res Int, 2014, 308654.
doi: 10.1155/2014/308654
[57]   CHENH, O’REILLYE J, SCHWARZSCHILDM A, et al.Peripheral inflammatory biomarkers and risk of Parkinson’s disease[J]Am J Epidemiol, 2007, 167( 1): 90-95.
doi: 10.1093/aje/kwm260
[58]   CAPURONL, MILLERA H. Immune system to brain signaling: neuropsychopharmacological implications[J]Pharmacol Ther, 2011, 130( 2): 226-238.
doi: 10.1016/j.pharmthera.2011.01.014
[59]   SVENSSONE, HORVÁTH-PUHÓE, THOMSENR W, et al.Vagotomy and subsequent risk of Parkinson’s disease[J]Ann Neurol, 2015, 78( 4): 522-529.
doi: 10.1002/ana.24448
[60]   BOTELHOJ, MASCARENHASP, MENDESJ J, et al.Network protein interaction in Parkinson’s disease and periodontitis interplay: a preliminary bioinformatic analysis[J]Genes, 2020, 11( 11): 1385.
doi: 10.3390/genes11111385
[61]   庞元捷, 吕 筠, 余灿清, 等. 多组学在慢性病病因学研究中的应用及其进展[J]. 中华流行病学杂志, 2021, 42(1): 1-9
PANG Yuanjie, LYU Jun, YU Canqing, et al. A multi-omics approach to investigate the etiology of non-communicable diseases: recent advance and applications[J]. Chinese Journal of Epidemiology, 2021, 42(1): 1-9. (in Chinese)
[1] WANG Wenni,CHEN Chaoqun,GU Xinhua. Research progress on effect of magnetic nanoparticle composite scaffold on osteogenesis[J]. J Zhejiang Univ (Med Sci), 2022, 51(1): 102-107.
[2] LU Xixuan,BAO Lisha,PAN Zongfu,GE Minghua. Immunotherapy for anaplastic thyroid carcinoma: the present and future[J]. J Zhejiang Univ (Med Sci), 2021, 50(6): 675-684.
[3] QIAN Chenhong,JIANG Liehao,XU Shiying,WANG Jiafeng,TAN Zhuo,XIN Ying,GE Minghua. Advances in targeted therapy for anaplastic thyroid carcinoma[J]. J Zhejiang Univ (Med Sci), 2021, 50(6): 685-693.
[4] ZHOU Jing,WANG Yan,XU Enping. Research progress on application of microhaplotype in forensic genetics[J]. J Zhejiang Univ (Med Sci), 2021, 50(6): 777-782.
[5] REN Yuan,CUI Gedan,GAO Yongxiang. Research progress on inflammatory mechanism of primary Sj?gren syndrome[J]. J Zhejiang Univ (Med Sci), 2021, 50(6): 783-794.
[6] MA Lijuan,WU Shuang,ZHANG Kai,TIAN Mei,ZHANG Hong. Progress on the application of positron emission tomography imaging of cannabinoid type 1 receptor in neuropsychiatric diseases[J]. J Zhejiang Univ (Med Sci), 2021, 50(5): 666-673.
[7] XUAN Zixue,ZHANG Yiwen,PAN Zongfu,ZHENG Xiaowei,HUANG Ping. Natural medicinal ingredients induce tumor ferroptosis and related mechanisms[J]. J Zhejiang Univ (Med Sci), 2021, 50(5): 601-606.
[8] QU Wenzheng,ZHUANG Yingliang,LI Xuekun. The roles of epigenetic modifications in neurodegenerative diseases[J]. J Zhejiang Univ (Med Sci), 2021, 50(5): 642-650.
[9] SUN Qi,CAO Wei,LUO Jianhong. The roles of GluN3-containing N-methyl-D-aspartate receptor in central nerve system[J]. J Zhejiang Univ (Med Sci), 2021, 50(5): 651-658.
[10] SHI Jianrong,MA Wangqian,TANG Huifang. Research progress of phosphodiesterase inhibitors in inflammatory bowel disease treatment[J]. J Zhejiang Univ (Med Sci), 2021, 50(5): 659-665.
[11] TANG Yue,KONG Yuanyuan. Hereditary tyrosinemia type Ⅰ: newborn screening, diagnosis and treatment[J]. J Zhejiang Univ (Med Sci), 2021, 50(4): 514-523.
[12] LIU Fei,FENG Chunyue,MAO Jianhua,FU Haidong. New-onset and relapsing glomerular diseases related to COVID-19 vaccination[J]. J Zhejiang Univ (Med Sci), 2021, 50(4): 524-528.
[13] HAN Lianshu. Genetic screening techniques and diseases for neonatal genetic diseases[J]. J Zhejiang Univ (Med Sci), 2021, 50(4): 429-435.
[14] HU Mangsha,WEI Shuli,ZHOU Wuyuan,WANG Pingli. Research progress on neonatal Fc receptor and its application[J]. J Zhejiang Univ (Med Sci), 2021, 50(4): 537-544.
[15] HU Jingyi,WANG Qingqing,LIU Yang. Research progress on proteasome subunits in regulating occurrence and development of hepatocellular carcinoma[J]. J Zhejiang Univ (Med Sci), 2021, 50(3): 396-402.